LON:SENS Sensyne Health (SENS) Share Price, News & Analysis → Top-Secret Government Project Revealed (From Porter & Company) (Ad) Free SENS Stock Alerts GBX 0.35 -0.18 (-33.33%) (As of 06/17/2022) Add Compare Share Share Today's Range 0.16▼ 0.6050-Day Range 0.35▼ 0.3552-Week Range 0.16▼ 155Volume4.45 million shsAverage Volume3.45 million shsMarket Capitalization£582,624.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Sensyne Health alerts: Email Address Ad Financial Markets DailyEstee Lauder, MAC, and other beauty brands are raving about this emerging NYSE AI companyA Little-known NYSE Company is Empowering the Beauty Industry with Innovative AI and AR Tools.Discover this unknown NYSE Tech SaaS company About Sensyne Health Stock (LON:SENS)Sensyne Health plc is a healthcare technology company that creates value from accelerating the discovery and development of new medicines and improving patient care through the analysis of real-world evidence from large databases of anonymised patient data in collaboration with NHS Trusts. These anonymised patient data are ethically sourced in that any analysis of anonymised patient data (and hence the Company’s access to it) must be pre-approved for each programme on a case-by-case basis by the relevant NHS Trusts. This is to ensure that the purpose of the anonymisation and the proposed analysis are subject to appropriate ethical oversight and information governance, including conformance with NHS principles, UK data protection law and applicable regulatory guidance. Sensyne Health is an early signatory to the Department of Health and Social Care’s ‘Initial Code of Conduct for data-driven health and care technology’.Read More SENS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SENS Stock News HeadlinesMarch 9, 2024 | forbes.comBest Collagen Powders Of 2024, According To ExpertsDecember 8, 2023 | bbc.comNHS data sale 'an invasion of privacy', campaigners sayAugust 3, 2023 | investopedia.comAre Health Insurance Premiums Tax-Deductible?June 8, 2023 | forbes.comBMI Calculator: Check Your Body Mass IndexMay 27, 2023 | forbes.comFind The Right Health Insurance For YouApril 24, 2023 | marketwatch.com2023, The Health Self-monitoring Market is Expected to Witness a Substantial Rise in RevenueApril 5, 2023 | marketwatch.comHealth Self-monitoring Market Size 2023 With Strategic Choice-Making Process, Identification of Main CorporationsMarch 15, 2023 | marketwatch.comHealth Self-monitoring Market Forecast 2023 To 2029 Size, Global Predictive AnalyticsMarch 13, 2023 | marketwatch.comHealth Self-monitoring Market 2023 Future Size And Growth of a Market By 2029February 10, 2023 | marketwatch.comGlobal Health Self-monitoring Market 2023-A Detailed Analysis till 2029December 23, 2022 | thetimes.co.ukIn the year business leaders lost it, the winner isDecember 13, 2022 | msn.comChief of reborn Sensyne Health secures funding for growth planOctober 15, 2022 | marketwatch.comArtificial Intelligence in Diabetes Management Market 2022 : Global Industry Overview, Sales Revenue, Demand and Forecast by 2029 | 109 Report PagesSeptember 27, 2022 | marketwatch.comArtificial Intelligence in Diabetes Management Market to show impressive growth of 35.56% CAGR during the period 2022-2027 | 126 Report PagesAugust 17, 2022 | msn.comUK hospitals lose millions after AI startup valuation collapsesJuly 9, 2022 | msn.comWhy Oxford biotech needs more than a shot in the arm to surviveJuly 6, 2022 | msn.comHealth trusts swapped patient data for shares in an AI firm. They may have lost millionsMay 21, 2022 | msn.comParmy Olson: Medical care increasingly depends on health tech AI. That may not be good for you.May 11, 2022 | washingtonpost.comToo Much AI May Not Be Good for Your Health or the NHSApril 19, 2022 | thetimes.co.ukSnow takes over as Sensyne ditches saleApril 19, 2022 | lse.co.ukAIM WINNERS & LOSERS: Cake Box trading strong; Sensyne falls furtherApril 19, 2022 | lse.co.ukSensyne Health shares plummet as AIM delisting proposedApril 19, 2022 | marketwatch.comSensyne Health Ends Sale Process, to Delist From AIMApril 19, 2022 | proactiveinvestors.comSensyne Health ends sale process as refinancing plans are fleshed outApril 13, 2022 | markets.businessinsider.comForm 8.3 - Lupus alpha Asset Management AG: Sensyne Health PLCSee More Headlines Receive SENS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sensyne Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorComputer and Technology Industry Health Information Services Sub-IndustryN/A Current SymbolLON:SENS CUSIPN/A CIKN/A Webwww.sensynehealth.com Phone44 3300 581845FaxN/AEmployees70Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E Ratio5.83 P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio6.02 Current Ratio2.26 Quick Ratio2.26 Sales & Book Value Annual Sales£7.81 million Price / Sales0.07 Cash FlowGBX 4.90 per share Price / Cash Flow0.07 Book ValueGBX 20.30 per share Price / Book0.02Miscellaneous Outstanding Shares166,464,000Free FloatN/AMarket Cap£582,624.00 OptionableNot Optionable BetaN/A A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for June 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key CompetitorsTrellus HealthLON:TRLSDeepVergeLON:DVRGEMIS GroupLON:EMISCranewareLON:CRWInstemLON:INSView All Competitors SENS Stock Analysis - Frequently Asked Questions How have SENS shares performed in 2024? Sensyne Health's stock was trading at GBX 0.35 on January 1st, 2024. Since then, SENS stock has increased by 0.0% and is now trading at GBX 0.35. View the best growth stocks for 2024 here. What other stocks do shareholders of Sensyne Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other Sensyne Health investors own include Fresenius Medical Care (FME), Green Plains Partners (GPP), Hershey (HSY), Gilead Sciences (GILD), Griffon (GFF), Emerald (EEX), DHX Media (DHXM), Ctrip.Com International (CTRP), Corus Entertainment (CJR) and Citizens Financial Group (CFG). How do I buy shares of Sensyne Health? Shares of SENS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:SENS) was last updated on 6/14/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredEstee Lauder, MAC, and other beauty brands are raving about this emerging NYSE AI companyA Little-known NYSE Company is Empowering the Beauty Industry with Innovative AI and AR Tools.Financial Markets Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredBuy this small stock before coming AI Tidal WaveThe internet generated more wealth than any other innovation in history - creating hundreds of thousands of ne...Chaikin Analytics | SponsoredElon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sensyne Health PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Sensyne Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.